Clinical Supply Study Complexity and Risk Assessment

Pfizer is a global biopharmaceutical company focused on research and development of vaccines and medicines to deliver breakthroughs that change patients' lives. To support this work, Pfizer's Global Clinical Supply (GCS) manages and supports hundreds of clinical trials at any one time. Our project will review the manual complexity and risk assessment work in GCS, and recommend an automation framework by conducting data analysis and machine learning along with implementing a proof of concept using the framework. This will enable timely response to changes and aid in efficiently allocating GCS resources.

Faculty Advisor:

• Lynn Andrea Stein

Team Members:

• Dre Hilton
• Evelyn Kessler
• Berwin Lan
• Miles Mezaki
• Trevor Zou